pHR_PGK_antiHer24D5-7_synNotch_Gal4VP64 Citations (2)

Originally described in: Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors.
Roybal KT, Williams JZ, Morsut L, Rupp LJ, Kolinko I, Choe JH, Walker WJ, McNally KA, Lim WA Cell. 2016 Oct 6;167(2):419-432.e16. doi: 10.1016/j.cell.2016.09.011. Epub 2016 Sep 29. PubMed Journal

---

Articles Citing pHR_PGK_antiHer24D5-7_synNotch_Gal4VP64

Articles
Engineering Human MAIT Cells with Chimeric Antigen Receptors for Cancer Immunotherapy. Dogan M, Karhan E, Kozhaya L, Placek L, Chen X, Yigit M, Unutmaz D. J Immunol. 2022 Oct 15;209(8):1523-1531. doi: 10.4049/jimmunol.2100856. Epub 2022 Sep 7. PubMed
Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles. Yaman S, Ramachandramoorthy H, Iyer P, Chintapula U, Nguyen T, Sabnani M, Kotadia T, Ghaffari S, Pop LM, Hannan R, Weidanz JA, Nguyen KT. Bioact Mater. 2024 Jan 11;34:422-435. doi: 10.1016/j.bioactmat.2023.12.027. eCollection 2024 Apr. PubMed

If you have published an article using this material, please email us at to have your article added to this page.